Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Drugs
Drugs
Page 10 of 30
Finance
U.S. slaps Mexican accountants with sanctions for timeshare scams funneling money to one of the world’s most notorious drug cartels
By
Fatima Hussein
and
The Associated Press
July 16, 2024
Lifestyle
The German billionaire behind the ‘Olympics on steroids’ is a dinosaur egg-collecting film producer who takes mushroom trips twice a year
By
Ryan Hogg
July 13, 2024
Health
Pharma giant Pfizer is trying to cash in on the weight loss drug craze with a new pill that could be a welcome needle-free alternative to pesky GLP-1 shots
By
Damian Garde
and
Bloomberg
July 11, 2024
Health
Struggling with money? It could be an early warning sign of dementia, ‘remarkable’ new research finds
By
Eva Roytburg
July 8, 2024
Finance
Peter Thiel’s doping-friendly Olympics alternative—the Enhanced Games—is in talks to raise $300 million as it prepares its first edition
By
Mark Bergen
,
Eyk Henning
and
Bloomberg
July 5, 2024
Health
Lilly wins FDA approval for new drug to slow Alzheimer’s
By
Madison Muller
,
Robert Langreth
and
Bloomberg
July 2, 2024
Commentary
Alzheimer’s made my mom unable to recognize her grandkids. Breakthroughs too late for her can change the disease’s trajectory—if diagnosis and treatment start early
By
Anne E. White
July 2, 2024
Finance
Walgreens shoppers are so fed up with prices it’s forcing the chain to close a ‘significant’ number of stores
By
Chris Morris
June 27, 2024
Health
A rare setback as Ozempic-maker Novo Nordisk takes a $820 million hit as its next wonder drug fails
By
Naomi Kresge
and
Bloomberg
June 27, 2024
Baby boomers are abusing marijuana at a higher rate as more Medicare beneficiaries turn to cannabis with ‘little other safe choices for pain or sleep’
By
Lindsey Leake
June 25, 2024
Health
Novo Nordisk plots $4.1 billion in U.S. factory amid Ozempic shortage, the same day it pulled out of its Ireland development project
By
Naomi Kresge
and
Bloomberg
June 25, 2024
Finance
A 45-year-old Los Angeles man was charged in a $50 million scheme to launder Mexican cartel money via rich Chinese nationals who wanted luxury goods, prosecutors allege
By
Amanda Gerut
June 19, 2024
Health
Mold colonies and liquid-flooded air purifiers: CVS sourced medication from tainted factories—and it has twice the amount of recalls on store-brand drugs than competitors
By
Sasha Rogelberg
June 11, 2024
Politics
Biden’s plan to save money on Medicare drugs risks leaving shelves empty, pharmacists say
By
Susan Jaffe
and
KFF Health News
June 11, 2024
Politics
Top assassin for the Sinaloa drug cartel, once described as ‘a complete psychopath’ with long history of gruesome acts, is extradited to U.S.
By
The Associated Press
May 25, 2024
Most Popular
AI
A man let ChatGPT sell his home. It beat every agent's estimate by $100K—and closed in 5 days
By
Jake Angelo
Success
Covid gave us hybrid work. The Iran War might give us a four-day week—and this time, experts say it could stick
By
Orianna Rosa Royle
Real Estate
Gen Z can’t afford a house. Some parents are choosing to fund their down payments over their college funds
By
Jake Angelo